Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
Josephine H Pedder,
No information about this author
Adam M. Sonabend,
No information about this author
Michael D Cearns
No information about this author
et al.
The Lancet Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Impact of Peripheral Inflammation on Blood–Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2440 - 2440
Published: March 9, 2025
The
blood–brain
barrier
(BBB)
is
essential
for
maintaining
brain
homeostasis
by
regulating
molecular
exchange
between
the
systemic
circulation
and
central
nervous
system.
However,
its
dysfunction,
often
driven
peripheral
inflammatory
processes,
has
been
increasingly
linked
to
development
progression
of
neurodegenerative
diseases
such
as
Alzheimer’s
Parkinson’s.
Emerging
evidence
suggests
that
gut–brain
axis
plays
a
key
role
in
BBB
integrity,
with
intestinal
dysbiosis
chronic
inflammation
contributing
disruption
through
immune
metabolic
pathways.
Furthermore,
selective
vulnerability
specific
regions
dysfunction
appears
be
influenced
regional
differences
vascularization,
activity,
permeability,
making
certain
areas
more
susceptible
processes.
This
review
explored
mechanisms
linking
inflammation,
gut
microbiota,
emphasizing
their
neurodegeneration.
A
comprehensive
literature
was
conducted
using
Web
Science,
PubMed,
Scopus,
Wiley,
ScienceDirect,
Medline,
covering
publications
from
2015
2025.
findings
highlight
complex
interplay
microbiota-derived
metabolites,
signaling,
underscoring
need
targeted
interventions
microbiome
modulation,
anti-inflammatory
therapies,
advanced
drug
delivery
systems.
heterogeneity
across
different
necessitates
region-specific
therapeutic
strategies.
Despite
advancements,
critical
knowledge
gaps
persist
regarding
precise
underlying
dysfunction.
Future
research
should
leverage
cutting-edge
methodologies
single-cell
transcriptomics
organ-on-chip
models
translate
preclinical
into
effective
clinical
applications.
Addressing
these
challenges
will
crucial
developing
personalized
approaches
mitigate
impact
diseases.
Language: Английский
Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data
Cells,
Journal Year:
2024,
Volume and Issue:
13(18), P. 1511 - 1511
Published: Sept. 10, 2024
Postencephalitic
parkinsonism
(PEP)
is
suggested
to
show
a
virus-induced
pathology,
which
different
from
classical
idiopathic
Parkinson's
disease
(PD)
as
there
no
α-synuclein/Lewy
body
pathology.
However,
PEP
shows
typical
clinical
representation
of
motor
disturbances.
In
addition,
compared
PD,
iron-induced
The
aim
this
preliminary
study
was
compare
with
PD
regarding
using
histochemistry
methods
on
paraffin-embedded
post-mortem
brain
tissue.
the
group,
iron
not
seen,
except
for
one
case
sparse
perivascular
depositions.
Rather,
offers
pathology
related
tau-protein/neurofibrillary
tangles,
mild
moderate
memory
deficits
only.
It
assumed
that
due
immunological
dysfunctions
causing
(neuro)inflammation-induced
neuronal
network
disturbances
events
trigger
parkinsonism.
absence
deposits
implies
cannot
be
treated
chelators.
therapy
L-Dopa
also
an
option,
only
leads
initial
slight
improvement
in
symptoms
isolated
cases.
Language: Английский
Temporal dynamics of neurovascular unit changes following blood-brain barrier opening in the putamen of non-human primates
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
377, P. 116 - 126
Published: Nov. 18, 2024
Low-intensity
focused
ultrasound
(LIFU)
combined
with
intravenously
circulating
microbubbles
has
recently
emerged
as
a
novel
approach
for
increasing
delivery
through
the
blood-brain
barrier
(BBB).
This
technique
safely
and
transiently
enables
therapeutic
agents
to
overcome
BBB,
which
typically
poses
significant
obstacle
treatment
of
brain
disorders.
However,
full
impact
LIFU
on
entire
neurovascular
unit
(NVU),
well
mechanisms
factors
involved
in
restoring
BBB
integrity
still
require
further
elucidation.
We
conducted
immunohistochemical
analyses
putamen
non-human
primates
monitor
changes
over
time
[immediately
post-treatment
(3
h)
at
7-
30-days
post-BBB
opening]
vascular,
glial,
immune
cells.
Additionally,
we
examined
dynamic
interactions
among
these
elements
their
role
restorative
process
level.
A
mild
inflammatory
response
primarily
involving
microglia,
astrocytes,
T-
B-lymphocytes
was
observed
treated
acutely
after
opening.
These
cells,
recruited
vascular
changes,
stimulate
upregulation
PDGFRβ,
pericyte-specific
marker,
VEGF-A,
pro-angiogenic
factor.
associated
sprouting
by
7
days
Importantly,
no
notable
long-term
alterations
were
NVU
30
results
offer
evidence
regarding
efficacy
safety
achieving
opening
primate
brain,
indicating
that
nearly
all
revert
baseline
within
post-treatment.
also
suggests
angiogenesis
may
play
an
important
Language: Английский